Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol (Δ9-THC) for chronic pancreatitis pain
2011-000647-24Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sodium oxybate in chronic pancreatitis (CP), sponsored by Radboud University Medical Center. Primary endpoint: Pain intensity (VASpain). Started May 2011; status: completed.
02
Drugs
sodium oxybate
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on 2011-000647-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000647-24.